Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
GBP | Fiscal Year Ending | | Latest |
(in millions) | Jan-15 | Jan-16 | Jan-17 | Jan-18 | Jan-19 | Jan-20 | Jan-21 | Jan-22 | Jan-23 | Jan-24 | | Jul-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 30 | (8) | 54 | 39 | (15) | 14 | 68 | (81) | (10) | (81) | | (31) |
% Growth | NA | -127.7% | -752.2% | -27.6% | -139.0% | -192.5% | 385.4% | -219.0% | -87.7% | 712.4% | | |
| | | | | | | | | | | | |
Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Gross Profit | 30 | (8) | 54 | 39 | (15) | 14 | 68 | (81) | (10) | (81) | | (31) |
% Revenue | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | 100.0% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (0) | (0) | (0) | (0) | (0) | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (2) | (1) | (2) | (2) | (2) | (3) | (2) | (2) | (2) | (2) | | (1) |
Other Inc / (Exp) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | (0) | 0 | | 0 |
Total Operating Exp | (2) | (2) | (2) | (3) | (3) | (3) | (3) | (2) | (2) | (1) | | (1) |
| | | | | | | | | | | | |
Operating Income | 28 | (10) | 52 | 36 | (18) | 11 | 66 | (83) | (12) | (82) | | (32) |
% Revenue | 94.1% | 121.8% | 96.4% | 92.9% | 117.0% | 80.8% | 96.3% | 102.5% | 120.1% | 101.8% | | 104.8% |
| | | | | | | | | | | | |
Interest Expense | (0) | 0 | 0 | 0 | 0 | 0 | 0 | (0) | (0) | (1) | | (1) |
Pre-tax Income | 28 | (10) | 52 | 36 | (18) | 11 | 66 | (83) | (12) | (83) | | (33) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (0) | (0) | (0) | (0) | (0) | (1) | (0) | (0) | (0) | (0) | | (0) |
Net Income to Company | 28 | (10) | 52 | 36 | (18) | 11 | 66 | (84) | (13) | (83) | | (33) |
% Margin | 93.1% | 125.5% | 95.7% | 92.0% | 119.8% | 76.7% | 96.0% | 102.9% | 125.8% | 102.7% | | 107.6% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 28 | (10) | 52 | 36 | (18) | 11 | 66 | (84) | (13) | (83) | | (33) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 28 | (10) | 52 | 36 | (18) | 11 | 66 | (84) | (13) | (83) | | (33) |
% Margin | 93.1% | 125.5% | 95.7% | 92.0% | 119.8% | 76.7% | 96.0% | 102.9% | 125.8% | 102.7% | | 107.6% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.42 | (0.16) | 0.79 | 0.56 | (0.29) | 0.17 | 1.26 | (1.37) | (0.20) | (1.34) | | (0.53) |
Diluted EPS (Continuing Ops) | 0.42 | (0.16) | 0.79 | 0.56 | (0.29) | 0.17 | 1.26 | (1.37) | (0.20) | (1.34) | | (0.53) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 65.97 | 65.89 | 65.31 | 63.56 | 62.89 | 61.68 | 51.96 | 60.89 | 62.01 | 61.98 | | 61.25 |
WA Diluted Shares Out. | 65.97 | 65.89 | 65.31 | 63.56 | 62.89 | 61.68 | 51.96 | 60.89 | 62.01 | 61.98 | | 61.25 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 28 | (10) | 52 | 36 | (18) | 11 | 66 | (83) | (12) | (83) | | (33) |
Addback: Net Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | 1 |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | | (0) |
Addback: Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 28 | (10) | 52 | 37 | (18) | 12 | 66 | (83) | (12) | (83) | | (32) |
% Margin | 94.3% | 120.3% | 96.7% | 93.8% | 116.2% | 82.2% | 96.5% | 102.4% | 118.0% | 101.9% | | 104.9% |
| | | | | | | | | | | | |
Adjusted EBIT | 28 | (10) | 52 | 37 | (18) | 12 | 66 | (83) | (12) | (83) | | (32) |
% Margin | 94.3% | 120.3% | 96.7% | 93.8% | 116.2% | 82.2% | 96.5% | 102.4% | 118.0% | 101.9% | | 104.9% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 28 | (10) | 52 | 36 | (18) | 11 | 66 | (84) | (13) | (83) | | (33) |
Addback: Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted Net Income | 28 | (10) | 52 | 36 | (18) | 11 | 66 | (84) | (13) | (83) | | (33) |
% Margin | 93.1% | 125.5% | 95.7% | 92.0% | 119.8% | 76.7% | 96.0% | 102.9% | 125.8% | 102.7% | | 107.6% |